Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€161.40

€161.40

1.490%
2.45
1.490%
€170.44
 
10.06.26 / Tradegate WKN: 939391 / Symbol: CRL / Name: Charles River Lb / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Charles River Labs Intl Stock

There is an upward development for Charles River Labs Intl compared to yesterday, with an increase of €2.45 (1.490%).
With 21 Buy predictions and not a single Sell prediction Charles River Labs Intl is an absolute favorite of our community.
As a result the target price of 170 € shows a slightly positive potential of 5.33% compared to the current price of 161.4 € for Charles River Labs Intl.

Pros and Cons of Charles River Labs Intl in the next few years

Pros
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Charles River Labs Intl vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Charles River Labs Intl 1.490% 4.028% 4.365% 22.088% -6.516% -12.259% -42.357%
Ligand Pharmaceuticals 0.910% 8.000% 14.894% 127.368% 30.120% 208.571% 121.903%
United Therapeutics 0.590% -0.148% -2.707% 95.394% 10.204% 121.288% 218.176%
Ionis Pharmaceuticals Inc. 0.060% -1.484% -0.437% 102.157% -6.210% 68.446% 103.512%

Comments

Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.
Ratings data for CRL provided by MarketBeat
Show more

Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Barclays PLC.
Ratings data for CRL provided by MarketBeat
Show more

Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.
Ratings data for CRL provided by MarketBeat
Show more